Work

Cefixime Allows Greater Dose Escalation of Oral Irinotecan: A Phase I Study in Pediatric Patients With Refractory Solid Tumors

Year: 2007

Type: article

Source: Yearbook of Oncology

DOI: 10.1016/s1040-1741(08)70477-9

Author: R.J. Arceci

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2322905068

FWCI:

Cites: 1

Cited by:

Related to: 10